Plunkett Research Online: Medicines Company (The)

MEDICINES COMPANY (THE) (MDCO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

The Medicines Company (TMC) is a global pharmaceutical company specializing in acute care hospital products. The firm acquires, develops and commercializes pharmaceutical products in late stages of development. The company has five marketed products: Angiomax, Carbavance, Ionsys, Minocin IV and Or.....



Medicines Company (The)
Ticker: MDCO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 973 290-6000
Fax: 973 656-9898
Address: 8 Sylvan Way
Parsippany, NJ 07054 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals Acquisition & Development
Acute Care Hospital Products
Anticoagulants
Blood Pressure Control
ContactsDescription
Clive MeanwellCEO/Director/Founder
William O'ConnorCFO
See More
The Medicines Company (TMC) is a global pharmaceutical company specializing in acute care hospital products. The firm acquires, develops and commercializes pharmaceutical products in late stages of development. The company has five marketed products: Angiomax, Carbavance, Ionsys, Minocin IV and Or.....See More See More

Auditor: ERNST & YOUNG LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Angiomax
Carbavance
Ionsys
Minocin IV
Orbactiv
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: